Pfizer Inc (PFE)
30.78
+0.60
(+1.97%)
USD |
NYSE |
Jul 26, 16:00
30.73
-0.04
(-0.15%)
After-Hours: 20:00
Pfizer Market Cap: 174.39B for July 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| July 25, 2024 | 171.02B |
| July 24, 2024 | 169.88B |
| July 23, 2024 | 167.16B |
| July 22, 2024 | 167.73B |
| July 19, 2024 | 169.83B |
| July 18, 2024 | 168.35B |
| July 17, 2024 | 170.17B |
| July 16, 2024 | 167.16B |
| July 15, 2024 | 164.90B |
| July 12, 2024 | 163.88B |
| July 11, 2024 | 162.40B |
| July 10, 2024 | 160.65B |
| July 09, 2024 | 157.08B |
| July 08, 2024 | 158.27B |
| July 05, 2024 | 158.95B |
| July 03, 2024 | 156.96B |
| July 02, 2024 | 157.70B |
| July 01, 2024 | 159.91B |
| June 28, 2024 | 158.55B |
| June 27, 2024 | 157.53B |
| June 26, 2024 | 155.38B |
| June 25, 2024 | 158.61B |
| June 24, 2024 | 160.70B |
| June 21, 2024 | 157.19B |
| June 20, 2024 | 157.19B |
| Date | Value |
|---|---|
| June 18, 2024 | 155.32B |
| June 17, 2024 | 152.88B |
| June 14, 2024 | 156.00B |
| June 13, 2024 | 156.68B |
| June 12, 2024 | 156.74B |
| June 11, 2024 | 158.83B |
| June 10, 2024 | 159.06B |
| June 07, 2024 | 161.95B |
| June 06, 2024 | 163.20B |
| June 05, 2024 | 167.45B |
| June 04, 2024 | 167.11B |
| June 03, 2024 | 166.09B |
| May 31, 2024 | 162.40B |
| May 30, 2024 | 159.80B |
| May 29, 2024 | 157.64B |
| May 28, 2024 | 160.36B |
| May 24, 2024 | 163.65B |
| May 23, 2024 | 162.57B |
| May 22, 2024 | 167.73B |
| May 21, 2024 | 161.84B |
| May 20, 2024 | 161.67B |
| May 17, 2024 | 162.29B |
| May 16, 2024 | 163.88B |
| May 15, 2024 | 163.31B |
| May 14, 2024 | 160.82B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.15B
Minimum
Apr 25 2024
343.79B
Maximum
Dec 16 2021
218.12B
Average
204.76B
Median
Market Cap Benchmarks
| Amgen Inc | 179.55B |
| Gilead Sciences Inc | 95.94B |
| Johnson & Johnson | 386.63B |
| Sarepta Therapeutics Inc | 13.64B |
| Moderna Inc | 46.82B |
Market Cap Related Metrics
| PS Ratio | 3.170 |
| Price to Book Value | 1.890 |
| Price to Free Cash Flow | 34.21 |
| Price | 30.78 |
| Earnings Yield | -0.19% |
| Operating PE Ratio | 146.53 |
| Normalized PE Ratio | 51.40 |